Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Subcutaneous vs Intramuscular Testosterone Therapy
NCT03091348Phase 4Completed
- Sponsor
- Men's Health Boston
- Start
- Aug 2017
- Primary completion
- Nov 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of testosterone cypionate in testosterone deficiency (TD) and Hypogonadism (2 arms), sponsored by Men's Health Boston. Primary endpoints: Serum Total Testosterone Concentration at Day 21 and Serum Calculated Free Testosterone Concentration at Day 21. Started Aug 2017; status: completed.
02
Drugs
testosterone cypionate
03
Conditions
testosterone deficiency (TD)Hypogonadism
Beyond the preview
Go deeper on NCT03091348.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03091348.